does semaglutide cause heart issues Semaglutide: What impact it really have on health? Insights into semaglutide cardiovascular research:

Results announced in December 2025 confirmed the Phase 2 findings at a longer timepoint (Lilly Press Release, Dec 2025): The 28.7% weight loss at 68 weeks exceeds both semaglutide (~15% in STEP trials) and tirzepatide (~22.5% in SURMOUNT trials) at similar timepoints

Second is that Pfizer and Novo Nordisk engaged in a bidding war for the company with Pfizer eventually winning out at a price of $10 billion

Lipo B-12 Injections support long-term weight management by maintaining energy levels, reducing fat buildup, and promoting a balanced metabolism

For optimal results, consider having a session once a week for a period of eight to ten weeks